SEI Investments
MLYS icon

SEI Investments’s Mineralys Therapeutics MLYS Stock Holding History

SEI Investments’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Sell
8,793
-2,899
-25% -$79.5K ﹤0.01% 2976
2026
Q1 		$317K Buy
11,692
+2,912
+33% +$85.4K ﹤0.01% 2809
2025
Q4 		$319K Sell
8,780
-1,085
-11% -$43.5K ﹤0.01% 2707
2025
Q3 		$374K Buy
+9,865
New +$213K ﹤0.01% 2367

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SEI Investments's MLYS Position: Q2 2026 in Review

SEI Investments reduced its Mineralys Therapeutics (MLYS) stake by 25% in Q2 2026, selling an estimated $79.5K and leaving 8,793 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

SEI Investments first reported a position in MLYS in Q3 2025 and has held it in 4 quarters since. The position peaked at $374K in Q3 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • SEI Investments held 8,793 shares of Mineralys Therapeutics worth $237K as of Q2 2026.
  • SEI Investments sold 2,899 Mineralys Therapeutics shares in Q2 2026, an estimated $79.5K.
  • Mineralys Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2976 holding.
  • SEI Investments first reported a position in Mineralys Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • SEI Investments's Mineralys Therapeutics position peaked at $374K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.